VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
VitaNova Life Sciences Corp
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026
- Market cap
- $37.52M
- P/E (TTM)
- –
- Dividend yield
- –
VitaNova Life Sciences statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Wholesale-Apparel, Piece Goods & Notions companies for comparison
Valuation
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Market Cap | $37.52M | $78.64M |
| Enterprise Value | $35.91M | $164.35M |
| PS Ratio | 11.57 | 0.28 |
| PB Ratio | 19.46 | 1.58 |
| P/TBV Ratio | 19.46 | 1.77 |
| P/OCF Ratio | 67.29 | 9.80 |
Enterprise value
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| EV / Sales | 11.07 | 0.40 |
Income (trailing twelve months)
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Revenue | $3.24M | $716.39M |
| Gross Profit | $872.33K | $163.57M |
| Operating Income | -$86.12K | -$30.27K |
| Net Income | -$114.10K | -$63.82K |
| EBITDA | -$86.12K | $2.60M |
| EPS (Diluted) | -$0.02 | $0.02 |
Margins
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Gross Margin | 26.9% | 14.7% |
| Operating Margin | -2.66% | 0.44% |
| Profit Margin | -3.52% | -0.13% |
| EBITDA Margin | -2.66% | 1.23% |
Returns
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -6.02% | -0.53% |
| Return on Assets (ROA) | -5.09% | -0.67% |
| Return on Invested Capital (ROIC) | -11.9% | 3.04% |
| Return on Capital Employed (ROCE) | -4.47% | 4.42% |
Growth
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 22.0% | 3.83% |
| Net Income Growth (YoY) | -113.3% | -4.31% |
| EPS Growth (YoY) | -118.2% | -3.40% |
| Revenue Growth (3Y CAGR) | 330.2% | 0.59% |
Balance sheet
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.60M | $9.33M |
| Net Cash (Debt) | $1.60M | -$1.85M |
| Net Cash Per Share | $0.19 | -$0.06 |
| Equity (Book Value) | $1.93M | $16.46M |
| Book Value Per Share | $0.23 | $0.34 |
| Tangible Book Value | $1.93M | $8.19M |
| Working Capital | $1.91M | $12.53M |
Financial position
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Current Ratio | 7.13 | 1.31 |
| Quick Ratio | 6.16 | 0.55 |
Cash flow (trailing twelve months)
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | $557.56K | $3.55M |
Efficiency
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Asset Turnover | 1.45 | 1.65 |
| Inventory Turnover | 15.28 | 9.79 |
| Revenue Per Employee | $463.32K | $1.02M |
| Profits Per Employee | -$16.30K | -$8.95K |
| Employee Count | 7 | 559 |
Dividends and yields
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Earnings Yield | -0.30% | -0.31% |
Shares
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 8,337,450 | 32,773,350 |
| Shares Change (YoY) | 0.00% | 0.00% |
| Shares Change (QoQ) | 0.00% | 0.00% |
| Float | 8,337,450 | 22,533,950 |
| Shares Held by Insiders | 0.00% | 8.34% |
Taxes
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Income Tax | $30.96K | $3.29M |
Scores
| Measure | VitaNova Life Sciences | Industry median |
|---|---|---|
| Altman Z-Score | 75.02 | 3.72 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from VitaNova Life Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.